UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nutritional Status, Body Surface, and Low Lean Body Mass/Body Mass Index Are Related to Dose Reduction and Severe Gastrointestinal Toxicity Induced by Afatinib in Patients With Non‐Small Cell Lung Cancer

The oncologist (Dayton, Ohio), 2015-08, Vol.20 (8), p.967-974

2015

Volltextzugriff (PDF)

Gene-expression profiles in lung adenocarcinomas related to chronic wood smoke or tobacco exposure

Respiratory research, 2016-04, Vol.17 (42), p.42-42, Article 42

2016

Volltextzugriff (PDF)

Long progression-free survival with first-line paclitaxel plus platinum is associated with improved response and progression-free survival with second-line docetaxel in advanced non-small-cell lung cancer

Cancer chemotherapy and pharmacology, 2014-10, Vol.74 (4), p.681-690

2014

Volltextzugriff (PDF)

A phase II trial of prolonged, continuous infusion of low-dose gemcitabine plus cisplatin in patients with advanced malignant pleural mesothelioma

Cancer chemotherapy and pharmacology, 2014-05, Vol.73 (5), p.975-982

2014

Volltextzugriff (PDF)

Proposals for the prevention of lung cancer in the health system of Mexico

Salud pública de México, 2016-04, Vol.58 (2), p.274-278

2016

Volltextzugriff (PDF)

Different mutation profiles and clinical characteristics among Hispanic patients with non-small cell lung cancer could explain the “Hispanic paradox”

Lung cancer (Amsterdam, Netherlands), 2015-11, Vol.90 (2), p.161-166

2015

Volltextzugriff (PDF)

Usefulness of serum carcinoembryonic antigen (CEA) in evaluating response to chemotherapy in patients with advanced non small-cell lung cancer: a prospective cohort study

BMC cancer, 2013-05, Vol.13 (1), p.254-254, Article 254

2013

Volltextzugriff (PDF)

Cómo optimizar los recursos en México para el tratamiento oncológico en la era de la inmunoterapia?

Gaceta Mexicana de Oncolog a, 2022-09, Vol.18 (2)

Macedo-Pérez, Eleazar Omar

2022

Volltextzugriff (PDF)

Randomized, open-label trial evaluating the preventive effect of tetracycline on afatinib induced-skin toxicities in non-small cell lung cancer patients

Lung cancer (Amsterdam, Netherlands), 2015-06, Vol.88 (3), p.282-288

2015

Volltextzugriff (PDF)

Reduction in Hepatocyte Growth Factor Serum Levels is Associated with Improved Prognosis in Advanced Lung Adenocarcinoma Patients Treated with Afatinib: a Phase II Trial

Targeted oncology, 2016-10, Vol.11 (5), p.619-629

2016

Volltextzugriff (PDF)

Response Assessment of ^sup 68^Ga-DOTA-E-[c(RGDfK)]^sup 2^ PET/CT in Lung Adenocarcinoma Patients Treated with Nintedanib Plus Docetaxel

The Journal of nuclear medicine (1978), 2018-03, Vol.59 (3), p.403

2018

Volltextzugriff (PDF)

Response Assessment of 68 Ga-DOTA-E-[c(RGDfK)] 2 PET/CT in Lung Adenocarcinoma Patients Treated with Nintedanib Plus Docetaxel

Journal of Nuclear Medicine, 2018-03, Vol.59 (3), p.403-409

2018

Volltextzugriff (PDF)

Hypertriglyceridemia associated with the use of capecitabine in a Mexican cohort

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e24107-e24107

2023

Volltextzugriff (PDF)

Survival of Patients with Advanced Non-Small Cell Lung Cancer Enrolled in Clinical Trials

Oncology, 2016, Vol.91 (4), p.185-193

2016

Volltextzugriff (PDF)

Cómo optimizar los recursos en México para el tratamiento oncológico en la era de la inmunoterapia?

Gaceta mexicana de oncología, 2019-06, Vol.18 (2), p.42-47

Macedo-Pérez, Eleazar Omar

2019

Volltextzugriff (PDF)

Response Assessment of 68Ga-DOTA-E-[c(RGDfK)]2 PET/CT in Lung Adenocarcinoma Patients Treated with Nintedanib Plus Docetaxel

The Journal of nuclear medicine (1978), 2018-03, Vol.59 (3), p.403-409

2018

Volltextzugriff (PDF)

National Clinical Practice Guidelines for the management of non-small cell lung cancer in early, locally advanced and metastatic stages. Extended version

Salud pública de México, 2019-05, Vol.61 (3), p.359-414

2019

Volltextzugriff (PDF)

Expression profiles in the histological subtypes of lung adenocarcinoma based on the classification of the IASLC/ERS/ATC

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e23226-e23226

2016

Volltextzugriff (PDF)

Association of response to whole-brain irradiation of brain metastases with molecular profile in non-small cell lung cancer

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.9096-9096

2016

Volltextzugriff (PDF)

Recomendaciones de oncólogos que trabajan en el ISSSTE para el tratamiento sistémico del cáncer de pulmón avanzado 2020

Latin american journal of clinical sciences and medical technology, 2020-08, Vol.2 (2), p.164-181

2020

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(20)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(12)
Female
(11)
Male
(11)
Middle Aged
(10)
Life Sciences & Biomedicine
(9)
Science & Technology
(9)
Oncology
(8)
Aged
(6)
Lung Neoplasms - Drug Therapy
(6)
Carcinoma, Non-Small-Cell Lung - Pathology
(5)
Lung Neoplasms - Pathology
(5)
Adult
(4)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(4)
Lung Cancer
(4)
Lung Neoplasms - Genetics
(4)
Prognosis
(4)
Treatment Outcome
(4)
Tumors
(4)
Afatinib
(3)
Antineoplastic Agents - Adverse Effects
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nutritional Status, Body Surface, and Low Lean Body Mass/Body Mass Index Are Related to Dose Reduction and Severe Gastrointestinal Toxicity Induced by Afatinib in Patients With Non‐Small Cell Lung Cancer

Gene-expression profiles in lung adenocarcinomas related to chronic wood smoke or tobacco exposure

Long progression-free survival with first-line paclitaxel plus platinum is associated with improved response and progression-free survival with second-line docetaxel in advanced non-small-cell lung cancer

A phase II trial of prolonged, continuous infusion of low-dose gemcitabine plus cisplatin in patients with advanced malignant pleural mesothelioma

Proposals for the prevention of lung cancer in the health system of Mexico

Different mutation profiles and clinical characteristics among Hispanic patients with non-small cell lung cancer could explain the “Hispanic paradox”

Usefulness of serum carcinoembryonic antigen (CEA) in evaluating response to chemotherapy in patients with advanced non small-cell lung cancer: a prospective cohort study

Cómo optimizar los recursos en México para el tratamiento oncológico en la era de la inmunoterapia?

Randomized, open-label trial evaluating the preventive effect of tetracycline on afatinib induced-skin toxicities in non-small cell lung cancer patients

Reduction in Hepatocyte Growth Factor Serum Levels is Associated with Improved Prognosis in Advanced Lung Adenocarcinoma Patients Treated with Afatinib: a Phase II Trial

Response Assessment of ^sup 68^Ga-DOTA-E-[c(RGDfK)]^sup 2^ PET/CT in Lung Adenocarcinoma Patients Treated with Nintedanib Plus Docetaxel

Response Assessment of 68 Ga-DOTA-E-[c(RGDfK)] 2 PET/CT in Lung Adenocarcinoma Patients Treated with Nintedanib Plus Docetaxel

Hypertriglyceridemia associated with the use of capecitabine in a Mexican cohort

Survival of Patients with Advanced Non-Small Cell Lung Cancer Enrolled in Clinical Trials

Cómo optimizar los recursos en México para el tratamiento oncológico en la era de la inmunoterapia?

Response Assessment of 68Ga-DOTA-E-[c(RGDfK)]2 PET/CT in Lung Adenocarcinoma Patients Treated with Nintedanib Plus Docetaxel

National Clinical Practice Guidelines for the management of non-small cell lung cancer in early, locally advanced and metastatic stages. Extended version

Expression profiles in the histological subtypes of lung adenocarcinoma based on the classification of the IASLC/ERS/ATC

Association of response to whole-brain irradiation of brain metastases with molecular profile in non-small cell lung cancer

Recomendaciones de oncólogos que trabajan en el ISSSTE para el tratamiento sistémico del cáncer de pulmón avanzado 2020

Suchergebnisse filtern